Sugar levels in UK soft drinks decrease in the wake of government tax
Researchers have discovered that UK drinks manufacturers have lowered the sugar levels in their drinks following the Soft Drinks Industry Levy (SDIL)
The Soft drink’s...
EFN: celebrating nurses and discussing the importance of digital healthcare
The European Federation of Nurses Associations (EFN) met at the European Parliament to discuss the hard work achieved by nurses and the impact of...
Forced organ harvesting: “I said: ‘you are breaking the law,’ and he replied: ‘yes’...
Falun Gong practitioner Zhang Yanhua was arrested in 2001 and held for seven years in a prison in Northern China, where she was tortured....
CURE group: what is happening to demand for emergency care?
Could the NHS be driving surplus demand and by extension additional strain on services such as emergency care?
The pressures of patient demand on emergency...
WHO: “Cancer should not be a death sentence for anyone, anywhere”
The World Health Organization (WHO) has outlined steps that could prevent seven million cancer-related deaths across the world
The guidelines spell out the need to...
XAG introduces drone disinfection operation to fight the coronavirus outbreak
Chinese tech company XAG has established a 5m-yuan fund to set up a drone disinfectant operation to curb the coronavirus outbreak
The coronavirus has now...
The digital future of the healthcare industry
ID Medical has analysed data from the NHS Long Term Plan to reveal what the future of healthcare will look like
Almost every aspect of...
Forced Organ Harvesting: “I’m going to China, they’re shooting my donor”
Health Europa Quarterly speaks to bioethicist Professor Wendy Rogers about forced organ harvesting and the ethical responsibilities of physicians and academics
Professor Wendy Rogers is...
Forced Organ Harvesting: “One of the worst mass atrocities of this century”
Health Europa Quarterly investigates the horrific practice of forced organ harvesting in Chinese prisons
In 2019, HEQ was contacted by representatives for survivors of the persecution,...
Forced organ harvesting: “This is beyond understanding”
Professor Jacob Lavee, co-founder of Doctors Against Forced Organ Harvesting, tells Health Europa Quarterly about organ theft and forced transplantation in China
Professor Jacob Lavee...
It’s time (of the month): Free period products for all schools and colleges
The Department for Education launches a fully funded scheme to ensure free period products are available in all schools and colleges across England.
The scheme...
‘Dementia Moonshot’: New report highlights six areas of critical investment
Alzheimer’s Research UK has created an ambitious spending plan for the government’s ‘Dementia Moonshot’ funding pledge.
Dementia is the nation’s biggest killer and has quickly...
PELC introduces GP service for the homeless
The Partnership of East London Cooperatives (PELC) is working with Redbridge Clinical Commissioning Group to provide a GP outreach service that offers health checks...
A spotlight on value-based healthcare with Jan-Philipp Beck
Creating high value for patients is the overarching goal of care delivery, but can the challenge of accomplishing value-based healthcare in the evolving health...
NHSX and interoperability in UK healthcare
Speaking at the HETT 2019 conference on technology in healthcare, Matthew Gould, CEO of NHSX, explained the need to integrate and scale technological innovation...
WHO guideline recommendations on digital health
Speaking at the HETT 2019 conference on healthcare and technology, WHO consultant Susannah Robinson, explained the WHO’s key guideline recommendations for the future of...
Cerebral palsy: first European drug approval in upper limb spasticity for a decade
Ipsen has announced the UK’s Medicine and Healthcare Products Regulatory Agency approved Dysport® for the treatment of spasticity of upper limbs in children with...
Fycompa: Eisai’s new anti-epileptic drug is ready for the market in China
Fycompa is a first in class anti-epileptic drug (AED) discovered and developed by the pharmaceutical company, Eisai and it's ready to be marketed in...
Why MDMA must be reclassified as a Schedule 2 drug
Amanda Feilding of the Beckley Foundation discusses the organisations new report ‘Roadmaps to Regulation: MDMA’ which recommends rescheduling MDMA to a Schedule 2 drug.
MDMA...
Smart Cells responds to ASA ruling on Cells4Life trust breach
Smart Cells have responded to ASA’s ruling on Cells4Life’s breach of consumer trust.
A recent investigation by the ASA into comparative claims and promotions made...
